Position in DHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,033,672
+$7,354,515 QoQ
Shares Held
68,743
+140.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $62,344,672 across 9 Diagnostics & Research names. DHR ranks #3 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDNA |
CareDx, Inc.
|
864,468 | $15,007,164 | |
| 2 | NTRA |
Natera, Inc.
|
69,767 | $13,952,702 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
68,743 | $13,033,672 | |
| 4 | MYGN |
Myriad Genetics Inc
|
2,088,492 | $9,398,214 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
356,359 | $5,666,108 | |
| 6 | GRAL |
GRAIL, Inc.
|
34,837 | $1,800,376 | |
| 7 | GH |
Guardant Health, Inc.
|
17,357 | $1,603,266 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
14,944 | $959,703 |
All Filings in DHR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,033,672 | 68,743 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $5,679,157 | 28,645 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $6,761,596 | 34,229 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $40,990,365 | 199,953 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||